SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-058316
Filing Date
2018-11-13
Accepted
2018-11-13 17:11:10
Documents
2
Period of Report
2018-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4866
2 POA DOCUMENT poa.txt EX-24.3_816863 3051
  Complete submission text file 0001209191-18-058316.txt   9288
Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
BRYNJELSEN SEAN (Reporting) CIK: 0001669976 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38738 | Film No.: 181179034

Mailing Address 12264 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SAN DIEGO CA 92130 858-704-4040
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations